Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
Clinical trial NCT02324049 · COMPLETED
Trial details
- NCT number
- NCT02324049
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2017-10-16
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.